Neuroprotective Effects of Antioxidative Flavonoids, Quercetin, (+)-dihydroquercetin and Quercetin 3-methyl Ether, Isolated from Opuntia Ficus-indica Var. Saboten
Authors
Affiliations
The flavonoids quercetin, (+)-dihydroquercetin, and quercetin 3-methyl ether were isolated from the ethyl acetate fractions of the fruits and stems of Opuntia ficus-indica var. saboten. In the present study, we evaluated their protective effects against oxidative neuronal injuries induced in primary cultured rat cortical cells and their antioxidant activities by using three different cell-free bioassays. Quercetin was found to inhibit H(2)O(2)- or xanthine (X)/xanthine oxidase (XO)-induced oxidative neuronal cell injury, with an estimated IC(50) of 4-5 micro g/ml. However, it was no more protective at concentrations of 30 micro g/ml and above. (+)-Dihydroquercetin concentration-dependently inhibited oxidative neuronal injuries, but it was less potent than quercetin. On the other hand, quercetin 3-methyl ether potently and dramatically inhibited H(2)O(2)- and X/XO-induced neuronal injuries, with IC(50) values of 0.6 and 0.7 micro g/ml, respectively. All three principles markedly inhibited lipid peroxidation and scavenged 1,1-diphenyl-2-picrylhydrazyl free radicals. In addition, quercetin and quercetin 3-methyl ether were shown to inhibit XO activity in vitro, with respective IC(50) values of 10.67 and 42.01 micro g/ml. These results indicate that quercetin, (+)-dihydroquercetin, and quercetin 3-methyl ether are the active antioxidant principles in the fruits and stems of Opuntia ficus-indica var. saboten exhibiting neuroprotective actions against the oxidative injuries induced in cortical cell cultures. Furthermore, quercetin 3-methyl ether appears to be the most potent neuroprotectant of the three flavonoids isolated from this plant.
Assessment of Opuntia ficus-indica supplementation on enhancing antioxidant levels.
Zaman R, Tan E, Bustami N, Amini F, Seghayat M, Ho Y Sci Rep. 2025; 15(1):3507.
PMID: 39875543 PMC: 11775336. DOI: 10.1038/s41598-025-87680-7.
Yeni Y, Genc S, Nadaroglu H, Hacimuftuoglu A Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39527310 DOI: 10.1007/s00210-024-03610-w.
Fang Y, Lin S, Chen C, Lo H Curr Issues Mol Biol. 2024; 46(5):4403-4416.
PMID: 38785535 PMC: 11120270. DOI: 10.3390/cimb46050267.
Elkomy M, Abo El-Ela F, Zaki R, Alsaidan O, Elmowafy M, Zafar A Pharmaceutics. 2023; 15(8).
PMID: 37631309 PMC: 10457845. DOI: 10.3390/pharmaceutics15082095.
Elkomy M, Zaki R, Alsaidan O, Elmowafy M, Zafar A, Shalaby K Pharmaceutics. 2023; 15(7).
PMID: 37513991 PMC: 10386734. DOI: 10.3390/pharmaceutics15071805.